Polymyalgia Rheumatica

Polymyalgia rheumatica (PMR) is an inflammatory rheumatic condition characterized by profound pain and stiffness in the shoulders, hip girdles, and neck. It predominantly affects individuals over the age of 50 and is strongly associated with giant cell arteritis (GCA).

The exact cause is unknown, but it is believed to result from an interaction between genetic predisposition (specifically HLA-DRB1 alleles) and environmental triggers, such as viral infections, which initiate an autoimmune response in the synovial tissues and bursae.

PMR involves an inflammatory process in the extra-articular structures. Histopathology reveals synovitis, tenosynovitis, and bursitis, particularly in the subacromial and subdeltoid bursa. Cytokine dysregulation, primarily involving Interleukin-6 (IL-6), plays a central role in systemic inflammation.

PMR is rare before age

1. Incidence increases with age, peaking between 70 and 80 years. Women are affected two to three times more frequently than men; Caucasians of Northern European descent have the highest prevalence.

• Age >50
• Caucasian ethnicity
• Family history of autoimmune disease
• Personal history of Giant Cell Arteritis
• Environmental exposures (seasonal variation suggests infectious triggers)

A. Early Symptoms

• Low-grade fever


• Malaise


• Unexplained weight loss B. Common Symptoms


• Bilateral shoulder pain/stiffness


• Hip girdle pain


• Morning stiffness lasting >45 minutes


• Difficulty rising from a chair C. Advanced Symptoms


• Proximal muscle atrophy


• Severe sleep disturbance due to pain


• Peripheral edema (pitting) D. Emergency Symptoms


• Sudden vision loss (indicative of GCA)


• Jaw claudication


• Scalp tenderness

Inspection may show limited range of motion (ROM) in shoulders/hips. Palpation reveals tenderness over the bursae. Neurological examination is typically normal (no primary muscle weakness, only pain-limited effort).

A. Clinical Assessment: ACR/EULAR criteria.
B. Laboratory Testing: Elevated ESR and CRP.
C. Imaging Studies: Ultrasound showing bursitis.
D. Functional Tests: Timed up and go test.
E. Biopsy Findings: Generally not indicated.
F. Genetic Testing: Not clinically used.
G. Differential Diagnosis: Rheumatoid arthritis, fibromyalgia, malignancy.

Erythrocyte Sedimentation Rate (ESR)
Type: Blood Test
Purpose: Inflammatory marker
Expected Findings: Elevated (>40 mm/hr)
Interpretation: Consistent with systemic inflammation C-Reactive Protein (CRP)
Type: Blood Test
Purpose: Acute phase reactant
Expected Findings: Elevated
Interpretation: Correlates with disease activity

Musculoskeletal Ultrasound (MSKUS)
Purpose: Visualize bursitis
Typical Findings: Subacromial/subdeltoid bursitis
Clinical Importance: Highly sensitive diagnostic tool

• Rheumatoid Arthritis (usually involves distal joints)
• Fibromyalgia (no elevated inflammatory markers)
• Polymyositis (shows muscle weakness and elevated CK)

• Steroid-induced osteoporosis
• Giant Cell Arteritis (blindness)
• Metabolic syndrome

A. Lifestyle Modifications: Gentle physical therapy.
B. Preventive Measures: Calcium and Vitamin D supplementation.
C. Medical Treatment

• Corticosteroids: Prednisone (15–20 mg/day).


• DMARDs: Methotrexate (for refractory cases).


• Biologics: Tocilizumab (IL-6 inhibitor). D. Surgical Treatment: N/A

Good; most patients achieve remission within 1–3 years. Recurrence is common during steroid tapering.

No primary prevention. Secondary prevention involves monitoring for GCA development.

The following homeopathic remedies have been historically indicated for symptoms associated with Polymyalgia Rheumatica. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Polymyalgia Rheumatica.